| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |